Healthcare

Meet your Healthcare Research team

UDG Healthcare plc

Delivering to plan; building a leading advisory business

UDG Healthcare has committed c.$250m in the last three years in delivering on its strategy to build an advisory business within Ashfield. This now accounts for over 20% of group profit...

Malin Corporation

H1 2019 results: value/price disconnect compelling

The modest 5% reduction in Malin’s IPEV stands in stark contrast to its 52% share price decline year-to-date. The latter is largely driven by overhang concerns due to Woodford IM’s...

Uniphar

High growth play on speciality Pharma and MedTech

Uniphar is a diversified healthcare services business focused on speciality pharma and medical devices. Structural industry growth, proprietary digital platforms and expansion into new...

Malin Corporation

New Chairman appointed

Liam Daniel has been appointed Chairman of Malin with immediate effect. He replaces Ian Curley, whose departure was flagged by Malin at its AGM in May. We view the appointment of Daniel,...

Mainstay Medical

Completes financing; operational runway extended to 2021

Mainstay has completed its equity and debt financing transactions, raising gross proceeds of €16.9m ($18.9m). The company now has sufficient capital to advance its two main strategic...

Malin Corporation

Kymab to receive up to $30m investment

LifeArc has made an initial $10m equity investment in Kymab and has committed to invest a further $20m. LifeArc is a UK medical research charity that has deep pockets after it...

Amryt Pharma

Acquisition of Aegerion; $60m equity raise; potential NASDAQ listing

Amryt has reached an agreement to acquire Aegerion Pharmaceuticals (subsidiary of Novelion) in an all-paper transaction. The deal will provide Amryt with an expanded commercial...

UDG Healthcare plc

H1 19: strong cashflow, 5% EPS upgrades on M&A

UDG has delivered a strong H1 19 performance. We estimate that underlying operating profit rose 6% and FCF conversion was very strong at 77%, putting UDG on track to meet its...

UDG Healthcare plc

Positive start to 2019; Ashfield now trading at up to a c.50% relative discount

UDG Healthcare’s (UDG) Q1 2019 update suggests that trading across the group is in-line with expectations. Guidance should also underpin confidence in market EPS numbers for 2019 and...

Venn Life Sciences

Partnership announcement

Venn has announced a partnership with Carrick Therapeutics, an Ireland and UK based biotech company developing treatments for aggressive forms of cancer. It has built a network of...